Large clinical trial to study repurposed drugs to treat COVID-19 symptoms

Using an ACTIV master protocol, the trial will focus on potential interventions for mild-to-moderate illness.

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *